The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
Mark Kacar,1 Sinisa Savic,1 Jeroen CH van der Hilst2,3 1Department of Clinical Immunology and Allergy, St James´s University Hospital, Leeds, UK; 2Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium; 3BIOMED Research Institute, University of Hasselt, Hasselt, B...
Enregistré dans:
Auteurs principaux: | Kacar M, Savic S, van der Hilst JCH |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/668b92cb15a746a4b9d8c98d09e8d710 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature
par: van der Hilst JC, et autres
Publié: (2016) -
Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever
par: Tolga Yildirim, et autres
Publié: (2021) -
Familial Mediterranean fever: current perspectives
par: Sönmez HE, et autres
Publié: (2016) -
The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study
par: Rabia Miray Kisla Ekinci, et autres
Publié: (2020) -
Familial Mediterranean fever: What associations to screen for?
par: Salem Bouomrani, et autres
Publié: (2020)